Results 101 to 110 of about 2,545,005 (248)
Sodium-glucose transporter 2 inhibitors have been identified as pleiotropic pharmacological agents with demonstrated efficacy in a wide range of pathologies.
Prația-Aron Diana-Ioana +2 more
doaj +1 more source
Abstract Sudden cardiac death is a cause of mortality due to malignant arrhythmias such as ventricular fibrillation (VF). Although action potential duration (APD) restitution is a method to assess arrhythmic susceptibility, repolarisation may depend on prior activation history, a phenomenon known as cardiac memory.
Bethan Roper‐Jones +4 more
wiley +1 more source
Spontaneous variability in ventricular ectopic activity during chronic antiarrhythmic therapy.
Previous determinations of variability in frequency of ventricular arrhythmias have been based on repeated recordings obtained in the absence of therapy. We evaluate variability during "effective" treatment with antiarrhythmic drugs.
J N Nanas +5 more
core +1 more source
Abstract figure legend The calcium‐activated chloride (ClCa) channel TMEM16A (also known as ANO1) plays critical roles in ion transport, neurotransmission and smooth muscle contraction. Dysregulation of TMEM16A channel activity contributes to the development and progression of various diseases.
Hisao Yamamura +4 more
wiley +1 more source
Background Catheter ablation and antiarrhythmic drug therapy are utilized for rhythm control in atrial fibrillation (AF), but their comparative effectiveness, especially with contemporary treatment modalities, remains undefined. We conducted a systematic
Subhash Chander +13 more
doaj +1 more source
Abstract figure legend A pre‐existing fibroblast signalling model was enhanced by integrating atrial‐specific components and reactions linked to atrial fibrosis and atrial fibrillation (AF). The analysis highlights the central role of Ca2⁺ signalling in driving profibrotic responses to AF‐relevant stimuli, angiotensin‐II and transforming growth factor ...
Najme Khorasani +5 more
wiley +1 more source
Investigational antiarrhythmic agents:promising drugs in early clinical development
Introduction: Although there have been important technological advances for the treatment of cardiac arrhythmias (e.g., catheter ablation technology), antiarrhythmic drugs (AADs) remain the cornerstone therapy for the majority of patients with ...
Shokoufeh Ghezelbash +5 more
core +1 more source
Background Patients with heart failure with reduced ejection fraction (HFrEF) frequently experience electrical disturbances, such as ventricular or atrial fibrillation (AF).
Alireza Arzhangzadeh +14 more
doaj +1 more source
Present and future of antiarrhythmic therapy for atrial fibrillation: A review
Despite the emergence and active development of interventional methods for the treatment of arrhythmias, to date, the use of antiarrhythmic drugs to recover and maintain sinus rhythm is the most significant and in demand in patients with paroxysmal and ...
Aida I. Tarzimanova
doaj +1 more source
Personalized Antiarrhythmic Therapy Using a Self-Managed Daily-ECG Device. [PDF]
Mattei E +4 more
europepmc +1 more source

